AONC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AONC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
American Oncology Network's sale of property, plant, equipment for the three months ended in Sep. 2024 was $0 Mil. It means American Oncology Network gained $0 Mil from selling property, plant, and equipment. American Oncology Network's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was $0 Mil.
Compared with last quarter ($0 Mil in Jun. 2024 ), American Oncology Network gained less money from selling property, plant, and equipment in Sep. 2024 ($0 Mil).
The historical data trend for American Oncology Network's Sale Of Property, Plant, Equipment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Oncology Network Annual Data | |||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | |||||
Sale Of Property, Plant, Equipment | - | 0.68 | 2.08 | 0.70 |
American Oncology Network Quarterly Data | |||||||||||
Dec20 | Dec21 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Sale Of Property, Plant, Equipment | Get a 7-Day Free Trial | - | - | - | 0.14 | - |
The amount earned to sell PPE.
Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of American Oncology Network's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.
Stephen Divers | director, officer: Chief Medical Officer | 133 HARMONY PARK CIRCLE, HOT SPRINGS AZ 71913 |
Todd Schonherz | director, officer: Chief Executive Officer | 14543 GLOBAL PARKWAY, 2ND FLOOR, FORT MEYERS FL 33913 |
Saba Capital Management, L.p. | 10 percent owner | 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174 |
Boaz Weinstein | 10 percent owner | 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174 |
David H Gould | officer: Chief Financial Officer | 7370 COLLEGE PARKWAY, SUITE 207, FORT MEYERS FL 33907 |
Erica Mallon | officer: General Counsel | 14543 GLOBAL PARKWAY, SUITE 110, FORT MEYERS FL 33913 |
Shalin Shah | director | 3402 W DR. MARTIN LUTHER KING JR. BLVD, TAMPA FL 33607 |
Vipul M Patel | director | 11704 SE 15TH CIRCLE, OCALA FL 34480 |
Vance Wright-browne | director | 22395 EDGEWATER DRIVE, PORT CHARLOTTE FL 33980 |
James Stith | director | ONE LETTERMAN DRIVE, CM200, SAN FRANCISCO CA 94129 |
Aea Growth Equity Fund Lp | 10 percent owner | 520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022 |
Aea Growth Equity Fund (parallel) Lp | 10 percent owner | 520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022 |
Ravi Yang Sarin | director | C/O ARES MANAGEMENT LLC, 2000 AVENUE OF THE STARS, 12TH FLOOR, LOS ANGELES CA 90067 |
Brian R Hoesterey | 10 percent owner | C/O AEA INVESTORS LP, 666 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10103 |
Kevin Nazemi | director, officer: Chief Executive Officer | 10485 NE 6TH ST, UNIT 3930, BELLEVUE WA 98004 |
From GuruFocus
By GlobeNewswire • 05-03-2024
By Marketwired • 07-11-2024
By Marketwired • 05-21-2024
By Marketwired • 04-25-2024
By Marketwired • 10-22-2024
By Marketwired • 10-18-2023
By Marketwired • 05-14-2024
By Marketwired • 11-07-2023
By Marketwired • 11-02-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.